News
Medtronic (NYSE:MDT) reports Q1 earnings on Aug 19. Can it sustain revenue growth amid EPS concerns? Learn about key trends, ...
50m
MarketBeat on MSNKratos Keeps Climbing After Q2, But Valuation Risk Looms
Since reporting Q2 2025 earnings, Kratos Defense & Security Solutions (NASDAQ: KTOS) has continued to be one of the most ...
17m
Capital Market on MSNKwality Pharma secures regulatory approval for anti-cancer drug Bleomycin in Mexico
According to an exchange filing, Bleomycin is a widely used anti-cancer medicine, effective in the treatment of Hodgkin's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results